RémyTrabelsi

Associate

Paris + 33.1.56.59.46.62

Connect:

Share

Rémy Trabelsi practices in the area of general corporate and securities law, focusing on capital markets and public M&A deals. He advises companies and financial institutions on a wide array of capital markets transactions including equity and debt offerings and initial public offerings (IPOs).

Since joining Jones Day in 2021, Rémy has advised the issuer in the IPO of Forsee Power on the regulated market of Euronext Paris. His experience also includes training at several British law firms and biotech companies.

Experience

  • Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholdersJones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.
  • Forsee Power completes €115 million offering and IPO on regulated market of Euronext in ParisJones Day advised Forsee Power in connection with its initial public offering on the regulated market of Euronext in Paris and an offering of up to €115 million.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.